By Daniella Parra Acumen Pharmaceuticals said it will present new research on its Alzheimer’s treatment candidate at the International Conference on Alzheimer’s and Parkinson’s Diseases 2026 in ...

Repurposing treatments to treat multiple conditions is quicker, safer, and less expensive than developing new ways to manage ...

Cognito raised $105 million as it awaits trial data that it hopes will convince the FDA to authorize its Alzheimer’s treatment device.

A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form ...

Forty-Hz auditory stimulation increased amyloid clearance markers in aged primates and produced lasting effects, supporting its potential as a non-invasive Alzheimer’s therapy. Scientists at the Kunmi ...

Scientists show that lecanemab clears amyloid plaques by engaging microglia through its Fc fragment, defining the cellular program behind its therapeutic effect ...

The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...

New research shows a simple blood test can predict the onset of Alzheimer’s symptoms, leading to earlier therapeutic care ...

The technique is not yet precise enough to predict a patient’s exact trajectory but could help find long-sought preventive treatment.

Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.